SunTrust Starts Glycomimetics (GLYC) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts GLYC Hot Sheet
Price: $0.16 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 56
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 56
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on Glycomimetics (NASDAQ: GLYC) with a Buy rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Glycomimetics click here. For more ratings news on Glycomimetics click here.
Shares of Glycomimetics closed at $8.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Baytex Energy (BTE:CN) (BTE) at Buy
- Wolfe Research Assumes Fifth Third Bancorp (FITB) at Outperform
- Wolfe Research Assumes Truist Financial (TFC) at Peerperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
